Current Use in Intensive Care Units by Intensivists of Antihypertensive Drugs

Current Use in Intensive Care Units by Intensivists of Antihypertensive Drugs

Multicenter, prospective and observational study of practices and impacts of the use of antihypertensive therapies in intensive medicine and intensive care

Multicenter, prospective observational cohort study on 200 patients, by doctor's questionnaire on the prescription of antihypertensive drugs in intensive care, follow-up over 72 hours of the prescription.

Inclusion Criteria:

• Adult patient
• Admitted to an intensive care unit
• Patient having presented a state of circulatory shock, defined by the need for continuous administration of a vasopressive amine for at least one hour, among: Noradrenaline, Adrenaline
• In whom the introduction of drug treatment for antihypertensive purposes is decided

Exclusion Criteria:

• Patient admitted to intensive care for a hypertensive emergency (hypertensive surge or malignant arterial hypertension leading to organ dysfunction
• Patient who has already received at least one anti-hypertensive drug during his stay in intensive care
• Cerebro-injured patient, proven or suspected cerebral edema, head trauma <1 month, decrease in cerebral perfusion measured
• Proven or suspected active bleeding
• Patient refusal of participation